Leading ITP clinicians come together and deliver consensus guidelines for the treatment of (ITP) in adult patients.
Welcome to the 2022 Spring Edition The Count. A quarterly newsletter created to update the ITP community on the latest updates and activities by ITP Australia and in the world of Immune Thrombocytopenia.
In this edition, we highlight the activities planned for 2022 ITP Awareness Week and how you can get involved, our recent trip to Seattle, Washington USA to meet with other international patient associations, focus on the importance of sleep, launch our NEW patient resources, and so much more!
Many of you have had the pleasure of meeting or hearing from Patricia. While she joined ITP Australia in early 2022, her ITP Journey started many years earlier. Read her story here.
HAVE YOUR SAY: Submit your letter to us, and we will hand deliver them when we travel to Canberra on Monday 5th September 2022.
The PBAC recommends removing restrictions to make it easier for ALL ITP Patients to access TPORAs.
Missed the ITP Australia Virtual Patient Conference for 2022, or would like to revisit one or more of the presentations? View them here.
The PBAC recommends a change for all listings and brands of Rituximab to be added to the Unrestricted Benefits listings.
ATAGI recommendation on the use of a 3rd primary dose of COVID-19 vaccine in individuals who are severely immunocompromised.
A joint statement from the Australian Technical Advisory Group on Immunisation (ATAGI) and the Thrombosis and Haemostasis society of Australia and New Zealand (THANZ) on Thrombosis with Thrombocytopenia Syndrome (TTS) and the use of COVID-19 Vaccine AstraZeneca.
ATAGI has released a number of recommendations relating to the COVID-19 Vaccine.
Dr Norman Swan hosts an ABC podcast called ‘Coronacast’, where they talk all things COVID-19. In a recent episode, he talks about the vaccines, the occurrence of blood clots and ITP.
Australian experts confident in AstraZeneca vaccine despite pause in Europe. 7.30 with Leigh Sales (ABC), Dr Norman Swan discussed the the most scrutinised vaccine rollout in history, with the COVID-19 vaccine.